Anyone selling at this price is definitely desperate or has completely given up. Fortunately, the technology has gotten noticed and it will become a must have to all diagnostic labs and research centers. I believe we will see Recaf become to Biocurex what Ipod has become to Apple. We will be rewarded, but let's make it a sure fire winner with an experienced CEO immediately following the next infusion of cash.
News 
Market Data 
Discover 
AI
